Discrepancies between author- and industry-reported disclosures of financial relationships at an annual gynecologic oncology research meeting
- 10 November 2020
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 160 (1), 260-264
- https://doi.org/10.1016/j.ygyno.2020.10.039
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K12 HD050121-12)
This publication has 14 references indexed in Scilit:
- Assessment of Conflicts of Interest in Robotic Surgical StudiesAnnals of Surgery, 2018
- Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational studyBMJ, 2017
- Debates about Conflict of Interest in Medicine: Deconstructing a Divided DiscourseJournal of Bioethical Inquiry, 2017
- Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline AuthorsJAMA Oncology, 2016
- Conflicts about Conflict of InterestCambridge Quarterly of Healthcare Ethics, 2016
- Sunshine Act: shedding light on inaccurate disclosures at a gynecologic annual meetingAmerican Journal of Obstetrics and Gynecology, 2016
- Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing CostsPLOS ONE, 2016
- Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparencyResearch Integrity and Peer Review, 2016
- Can We Trust Positive Findings of Intervention Research? The Role of Conflict of InterestPrevention Science, 2016
- Limiting the Influence of Pharmaceutical Industry Gifts on Physicians: Self-Regulation or Government Intervention?Journal of General Internal Medicine, 2009